Tyrosine kinase signaling-independent MET-targeting with CAR-T cells.
Anna QinYuan QinJoseph LeeAnna MusketMingyao YingGiedre KrenciuteFrancesco M MarincolaZhi Q YaoPhillip R MusichQian XiePublished in: Journal of translational medicine (2023)
We generated and characterized MET-specific CAR-T cells for targeting HCC with MET overexpression regardless of MET activation. Compared with MET-CAR.4-1BBζ, MET-CAR.CD28ζ T cells showed a higher anti-HCC potency but also a higher level of T cell exhaustion. While MET-CAR.CD28ζ is preferred for further development, overcoming the exhaustion of MET-CAR-T cells is necessary to improve their therapeutic efficacy in vivo.